Oxysterols produced by CH25H during cholesterol metabolism have been shown to play an important role in the immune response. In this study we report the genetic characterization of CH25H in patients diagnosed with multiples sclerosis (MS) or neuromyelitis optica (NMO), for the identification of genetic variants affecting disease susceptibility and course. Exome analysis in 212 MS and 14 NMO patients identified a rare CH25H p.Q17H mutation in two NMO patients of Asian ancestry. In addition, association analysis of common CH25H variants identified a nominally significant association with MS patients presenting a clinical course consistent with primary progressive disease.
Introduction
Recent studies have indicated that cholesterol metabolism is important for the immune response, with dyslipidaemia resulting in worsening inflammatory activity and disease progression in multiple sclerosis (MS) patients (Chalmin et al., 2015; Tall and Yvan-Charvet, 2015) . In addition, cholesterol synthesis and transport in oligodendrocytes have been shown to be essential for optimal myelination and remyelination (Chalmin et al., 2015) . Cholesterol 25-hydroxylase (CH25H) converts cholesterol into the oxysterol 25-hydroxycholesterol (25-HC), and is the rate-limiting enzyme in the conversion of cholesterol to serum oxysterols, which regulate cellular proliferation and differentiation of cells of the innate and adaptive immune system (Spann and Glass, 2013) . The expression of CH25H is induced by type I interferons (IFNs), potent cytokines used for the treatment of inflammatory diseases, including MS. Activation of CH25H has been shown to increase the concentration of 25-HC, reducing interleukin-1B transcription and repressing its inflammasome-mediated activation (Reboldi et al., 2014; Tall and Yvan-Charvet, 2015) .
CH25H knockout mice present marked changes in their inflammatory response, with increased frequencies of IL17A + T cells and neutrophil counts (Reboldi et al., 2014) . Interestingly, the induction of experimental autoimmune encephalomyelitis (EAE) in these animals leads to a less severe disease course and delayed onset of symptoms, due to limited trafficking of activated lymphocytes to the central nervous system (Chalmin et al., 2015) . Taken together this data suggest that the synthesis of oxysterol from cholesterol metabolism may play a role in the onset and progression of autoimmune inflammatory diseases. Since CH25H is the rate-limiting enzyme in this process, we set to assess the presence of rare coding variants in CH25H which may affect protein function in patients diagnosed with MS or neuromyelitis optica (NMO), as well as evaluate the role of common genetic variants on MS susceptibility and course in a large case-control series from Canada.
Material and methods
A total of 2221 MS patients, 14 NMO patients and 882 healthy controls recruited through the Canadian Collaborative Project on the Genetic Susceptibility to Multiple Sclerosis (CCPGSMS) were characterized in this study (Sadovnick et al., 1998) . With the exception of 33 patients of Asian ethnicity (19 diagnosed with MS and 14 with NMO), all subjects were of European ancestry. The Research Ethic Board (REB) at the University of British Columbia approved the study, and all participants provided informed consent.
MS and NMO patients were diagnosed using published criteria (Polman et al., 2005; Poser et al., 1983; Wingerchuk et al., 2006) . The mean age at blood collection was 46.7 years (SD ± 11.7) for MS patients, 42.9 years (SD ± 13.6) for NMO patients and 67.2 years (SD ± 9.8) for controls, with a male to female ratio of 1:2.75, 1:13 and 1:0.96 respectively. The mean age at MS onset was 31.0 years (SD ± 9.7), with a median Expanded Disability Status Scale (EDSS) score of 3.5 and an average of 4.0 (SD ± 2.6) (Kurtzke, 1983) . The average age at onset for NMO patients was 34.3 years (SD ± 10.1) with a median EDSS score of 3 and an average of 3.8 (SD ± 1.8). Detailed clinical course at the
